Gentamicin-Attenuated Leishmania infantum Vaccine: Protection of Dogs against Canine Visceral Leishmaniosis in Endemic Area of Southeast of Iran

PLoS Neglected Tropical Diseases

Volumn 8, Issue 4, 2014, Pages

  Daneshvar, Hamid ^a   Namazi, Mohammad Javad ^b   Kamiabi, Hossein ^c   Burchmore, Richard ^d   Cleaveland, Sarah ^d   Phillips, Stephen ^d  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Faculty of Medical Sciences   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; IMMUNOGLOBULIN G ANTIBODY; LEISHMANIA INFANTUM VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DNA EXTRACTION; DOG; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION AND FOLLOW UP; GLOMERULONEPHRITIS; IMMUNOFLUORESCENCE TEST; IRAN; LEISHMANIA INFANTUM; LEISHMANIASIS; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROMASTIGOTE; VACCINATION; WESTERN BLOTTING;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, PROTOZOAN; DNA, PROTOZOAN; DOG DISEASES; DOGS; GENTAMICINS; IRAN; LEISHMANIA INFANTUM; LEISHMANIASIS VACCINES; LEISHMANIASIS, VISCERAL; VACCINATION; VACCINES, ATTENUATED;

EID: 84897942799     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002757     Document Type: Article

References (41)

1. Moreno J, Alvar J, (2002) Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol 18: 399-405.
2. Baneth G, Koutinas AF, Solano-Gallego L, Bourdeau P, Ferrer L, (2008) Canine leishmaniosis- new concepts and insights on an expanding zoonosis: part one. Trends Parasitol 24: 324-330.
3. Mahmoudvand H, Mohebali M, Sharifi I, Keshavarz H, Hajjaran H, et al. (2011) Epidemiological aspects of visceral leishmaniasis in Baft district, Kerman Province, Southeast of Iran. Iranian J Parasitol 6: 1-11.
4. Dantas-Torres F, (2009) Canine leishmaniosis in South America. Parasit Vectors 2 Suppl 1: S1.
5. Courtenay O, Quinnell RJ, Garcez LM, Shaw JJ, Dye C, (2002) Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J Infect Dis 186: 1314-1320.
6. Sundar S, (2009) Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6: 849-854.
7. Rappuoli R, Del Giudice G (1999) Identification of vaccine targets. In: Paoletti LC, McInnes PM, eds. Vaccines: from concept to clinic. Boca Raton, FL: CRC Press. pp. 1-17.
8. Bertholet S, Goto Y, Carter L, Bhatia A, Howard RF, et al. (2009) Optimized subunit vaccine protects against experimental leishmaniasis. Vaccine 23: 7036-7045.
9. Goto Y, Bhatia A, Raman VS, Liang H, Mohamath R, et al. (2011) KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis. Clin Vaccine Immunol 18: 1118-1124.
10. Hess J, Schaible U, Raupach B, Kaufmann SH, (2000) Exploiting the immune system: toward new vaccines against intracellular bacteria. Adv Immunol 75: 81-88.
11. Daneshvar H, Coombs GH, Hagan P, Phillips RS, (2003) Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with attenuated lines. J Infect Dis 187: 1662-1668.
12. Bates PA, Tetley L, (1993) Leishmania mexicana: induction of metacyclogenesis by cultivation of promastigotes at acidic pH. Exp Parasitol 76: 412-423.
13. Schuster FL, Sullivan JJ, (2002) Cultivation of clinically significant hemoflagellates. Clin Microbiol Rev 15: 374-389.
14. Magnet S, Blanchard JS, (2005) Molecular insights into aminoglycoside action and resistance. Chem Rev 105: 477-498.
15. Daneshvar H, Wyllie S, Phillips RS, Hagan P, Burchmore R, (2012) Comparative proteomics profiling of a gentamicin-attenuated Leishmania infantum cell line identifies key changes in parasite thiol-redox metabolism. J Proteomics 75: 1463-1471.
16. Romao S, Castro H, Sousa C, Carvalho S, Tomás AM, (2009) The cytosolic tryparedoxin of Leishmania infantum is essential for parasite survival. Int J Parasitol 39: 703-711.
17. Daneshvar H, Molaei MM, Afshar RM, Kamiabi H, Burchmore R, et al. (2009) Gentamicin-attenuated Leishmania infantum: A clinicalpathological study in dogs. Vet Immunol Immunopathol 129: 28-35.
18. Daneshvar H, Sedghi F, Dabiri S, Molaei MM, Kamiabi H, et al. (2012) Alteration in mononuclear cell subpopulations in dogs immunized with gentamicin-attenuated Leishmania infantum. Parasitol 139: 1689-1696.
19. Daneshvar H, Molaei MM, Kamiabi H, Burchmore R, Hagan P, et al. (2010) Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis. Parasite Immunol 32: 722-730.
20. Daneshvar H, Mahmmodi Z, Kamiabi H, Phillips RS, Burchmore R, (2014) Dogs vaccinated with gentamicin-attenuated Leishmania infantum or infected with wild-type parasite can be distinguished by Western blotting. Parasite Immunol DOI: 10.1111/pim.12108.
21. Motovali Emamia M, Yazdib M, (2008) Entomological survey of phlebotomine sand flies (Diptera: Psychodidae) in a focus of visceral leishmaniasis in central Iran. J Vector Borne Dis 45: 38-43.
22. Solano-Gallego L, Miró G, Koutinas A, Cardoso L, Pennisi MG, et al. (2011) LeishVet guidelines for the practical management of canine leishmaniasis. Parasite Vectors 4: 86.
23. Tafuri WL, de Oliveira MR, Melo MN, Tafuri WL, (2001) Canine visceral leishmaniosis: a remarkable histopathological picture of one case reported from Brazil. Vet Parasitol 96: 203-212.
24. Carrera L, Fermín ML, Tesouro M, García P, Rollá n E, et al. (1996) Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers. Exp Parasitol 82: 139-146.
25. Fernández-Pérez FJ, Mendez S, de la Fuente C, Cuquerella M, Gomez MT, et al. (1999) Value of Western blotting in the clinical follow-up of canine leishmaniasis. J Vet Diagn Investig 11: 170-173.
26. Rodgers MR, Popper SJ, Wirth DF, (1990) Amplification of kinetoplast DNA as a tool in the detection and diagnosis of Leishmania. Exp Parasitol 71: 267-275.
27. Pinelli E, Killick-Kendrick R, Wagenaar J, Bernadina W, Del Real G, et al. (1994) Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect Immunol 62: 229-235.
28. Veras PST, dos-Santos WLC, Imeida ATF, Rodrigues CAT, (2010) Primary immune response and parasite dissemination in canine visceral leishmaniasis. Animal Biol J 1: 205-221.
29. Deplazes P, Smith NC, Arnold P, Lutz H, Eckert J, (1995) Specific IgG1 and IgG2 antibody response of dogs to Leishmania infantum and other parasites. Parasite Immunol 17: 451-458.
30. Mohebali M, Edrissian GH, Shirzadi MR, Akhoundi B, Hajjaran H, et al. (2011) An observational study on the current distribution of visceral leishmaniasis in different geographical zones of Iran and implication to health policy. Travel Med Infec Dis 9: 67-74.
31. Sharifi I, Daneshvar H, (1996) The prevalence of visceral leishmaniasis in suspected canine reservoirs in southeastern Iran. Iranian J Basic Med Sci 21: 130-134.
32. Silva ES, Gontijo CM, Pirmez C, Fernandes O, Brazil RP, (2001) Short report: detection of Leishmania DNA by polymerase chain reaction on blood samples from dogs with visceral leishmaniasis. Am J Trop Med Hyg 65: 896-898.
33. Sideris V, Papadopoulou G, Dotsika E, Karagouni E, (1999) Asymptomatic canine leishmaniasis in Greater Athens area, Greece. Eur J Epidemiol 15: 271-276.
34. Franca-Silva JC, da Costa RT, Siqueira AM, Machado-Coelho GL, da Costa CA, et al. (2003) Epidemiology of canine visceral leishmaniosis in the endemic area of Montes Claros Municipality, Minas Gerais State, Brazil. Vet Parasitol 111: 161-173.
35. Santarém N, Tomás A, Ouaissi A, Tavares J, Ferreira N, et al. (2005) Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment. Immunol Lett 101: 18-23.
36. Otranto D, Paradies P, de Caprariis D, Stanneck D, Testini G, et al. (2009) Toward diagnosing Leishmania infantum infection in asymptomatic dogs in an area where leishmaniasis is endemic. Clin Vaccine Immunol 16: 337-343.
37. Ferreira Ede C, de Lana M, Carneiro M, Carneiro M, Reis AB, et al. (2007) Comparison of serological assays for the diagnosis of canine visceral leishmaniasis in animals presenting different clinical manifestations. Vet Parasitol 146: 235-241.
38. Mettler M, Grimm F, Capelli G, Camp H, Deplazes P, (2005) Evaluation of enzyme-linked immunosorbent assays, an immunofluorescent-antibody test, and two rapid tests (immunochromatographic-dipstick and gel tests) for serological diagnosis of symptomatica and asymptomatic Leishmania infections in dogs. J Clin Microbiol 43: 5515-5519.
39. Harrus S, Waner T, Friedmann-Morvinski D, Fishman Z, Bark H, et al. (2003) Down-regulation of MHC class II receptors of DH82 cells, following infection with Ehrlichia canis. Vet Immunol Immunopathol 96: 239-243.
40. da Silva VO, Borja-Cabrera GP, Correia Pontes NN, de Souza EP, Luz KG, et al. (2000) A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN). Vaccine 19: 1082-1092.
41. Lemesre JL, Holzmuller P, Cavaleyra M, Goncalves RB, Hottin G, et al. (2005) Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23: 2825-2840.